About forzinity

forzinity is a personal research site. It exists because forzinity (elamipretide / ss-31) became, almost overnight, one of the most-searched molecules in mitochondrial research — while the useful knowledge about it stayed scattered across a prescribing-information PDF, a dozen trial registries, conference abstracts, pricing databases and forum threads. This site gathers that record into one place, grades every claim by evidence tier, and documents what the data does and does not support.

The site is organized as a pillar-cluster reference. Four long-form pillars anchor the field: what is forzinity (the brand and its research record), elamipretide (ss-31) (the molecule), the clinical-trials record, and forzinity cost and market access. Every shorter article belongs to exactly one cluster and links back to its pillar, so each topic keeps a clean, closed link neighborhood.

It is not a store, an affiliate site, or an advisory service. We sell nothing, link no sellers, take no placements or commissions, and have no financial relationship with Stealth BioTherapeutics, Pharmanovia, any specialty pharmacy, or any research-chemical supplier. Where the site describes market channels — as on the forzinity for sale and research-channel market pages — it does so as industry research, never as purchasing guidance.

It is also not a medical resource. Nothing on this site advises human or veterinary use of any compound, and no page answers individual-treatment questions. The scope of everything published here is bounded by the disclaimer, and the sourcing and update standards are documented in the editorial policy.

Every page is built from public documents: the FDA prescribing information, trial registry records and publications, manufacturer public disclosures, pricing databases, and the peer-reviewed basic-science literature on ss-31. Claims carry evidence tiers, numbers are quoted with their source and date, and market data pages state plainly when a channel is empty — as the coupon-channel page does — rather than padding the gap with invented programs.

Corrections are welcome and taken seriously: if a number, date or attribution on any page is wrong, it gets fixed and noted. Use the contact page; we read everything.